Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non–Small Cell Lung Cancer
Year: 2013
Type: article
Source: Science Translational Medicine
Authors: Ganapati V. Hegde, Cecile C. de la Cruz, Cecilia Chiu, Navneet Alag, Gabriele Schaefer, Lisa Crocker, Sarajane Ross, David Goldenberg, Mark Merchant, Janet Tien, Lily Shao, Leslie Roth, Siao-Ping Tsai, Scott Stawicki, Zhaoyu Jin, Shelby K. Wyatt, Richard A. D. Carano, Yanyan Zheng, E. Alejandro Sweet-Cordero, Yan Wu, Erica L. Jackson
Institutions: Genentech, Stanford Medicine, Stanford University
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2100348249
